By mystock
Unisem - Feverish Chengdu
Timely expansion in China combined with global demand recovery ensure an impressive CAGR of 90% for 2009-11. Catalysts are above-consensus earnings, IPO-worthy Unisem Chengdu and cheap valuations. Initiate with BUY Initiating coverage with a BUY call and a target price of RM2.26, based on a three-year...
You’re about to leave Blogged.my for an external website we don’t control. Its content is the responsibility of its author, not an endorsement by us.
We’ll take you there in a moment. Logged-in members go straight to posts — why not sign up?